Burning Rock Biotech Ltd (NASDAQ:BNR) — Market Cap & Net Worth
Market Cap & Net Worth: Burning Rock Biotech Ltd (BNR)
Burning Rock Biotech Ltd (NASDAQ:BNR) has a market capitalization of $70.07 Million ($70.07 Million) as of June 26, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20582 globally and #4597 in its home market, demonstrating a -2.21% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Burning Rock Biotech Ltd's stock price $7.95 by its total outstanding shares 8813858 (8.81 Million). Review Burning Rock Biotech Ltd total liabilities to assess the company's total debt and financial obligations.
Burning Rock Biotech Ltd Market Cap History: 2020 to 2026
Burning Rock Biotech Ltd's market capitalization history from 2020 to 2026. Data shows change from $2.04 Billion to $70.07 Million (-43.37% CAGR).
Index Memberships
Burning Rock Biotech Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.44 Trillion | 0.00% | #585 of 976 |
|
NASDAQ Composite
IXIC
|
$39.75 Trillion | 0.00% | #1984 of 3165 |
Weight: Burning Rock Biotech Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Burning Rock Biotech Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Burning Rock Biotech Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.33x
Burning Rock Biotech Ltd's market cap is 0.33 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $2.04 Billion | $429.90 Million | -$407.24 Million | 4.74x | N/A |
| 2021 | $839.96 Million | $507.86 Million | -$796.70 Million | 1.65x | N/A |
| 2022 | $198.31 Million | $563.24 Million | -$971.23 Million | 0.35x | N/A |
| 2023 | $81.97 Million | $537.43 Million | -$653.69 Million | 0.15x | N/A |
| 2024 | $59.49 Million | $515.82 Million | -$346.63 Million | 0.12x | N/A |
| 2025 | $177.60 Million | $539.57 Million | -$55.35 Million | 0.33x | N/A |
Competitor Companies of BNR by Market Capitalization
Companies near Burning Rock Biotech Ltd in the global market cap rankings as of June 26, 2026.
Key companies related to Burning Rock Biotech Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #113 globally with a market cap of $190.01 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #169 globally with a market cap of $136.47 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #625 globally with a market cap of $43.78 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #645 globally with a market cap of $42.42 Billion USD ( CN¥289.92 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #113 | Thermo Fisher Scientific Inc | NYSE:TMO | $190.01 Billion | $505.75 |
| #169 | Danaher Corporation | NYSE:DHR | $136.47 Billion | $193.21 |
| #625 | IDEXX Laboratories Inc | NASDAQ:IDXX | $43.78 Billion | $554.94 |
| #645 | WuXi AppTec Co Ltd | SHG:603259 | $42.42 Billion | CN¥117.22 |
Burning Rock Biotech Ltd Historical Marketcap From 2020 to 2026
Between 2020 and today, Burning Rock Biotech Ltd's market cap moved from $2.04 Billion to $ 70.07 Million, with a yearly change of -43.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $70.07 Million | -60.55% |
| 2025 | $177.60 Million | +198.52% |
| 2024 | $59.49 Million | -27.42% |
| 2023 | $81.97 Million | -58.67% |
| 2022 | $198.31 Million | -76.39% |
| 2021 | $839.96 Million | -58.74% |
| 2020 | $2.04 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 26th, 2026 the market cap of Burning Rock Biotech Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $70.07 Million USD |
| MoneyControl | $70.07 Million USD |
| MarketWatch | $70.07 Million USD |
| marketcap.company | $70.07 Million USD |
| Reuters | $70.07 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Burning Rock Biotech Ltd
Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company offers next-generation sequencing (NGS)-based tissue, liquid biopsy cancer therapy selection, and prognosis prediction test… Read more